BlackRock Health Sciences Trust (NYSE:BME) Shares Cross Below 50-Day Moving Average – Time to Sell?

BlackRock Health Sciences Trust (NYSE:BME) passed below its fifty day moving average during trading on Friday . The stock has a fifty day moving average of $41.28 and traded as low as $37.51. BlackRock Health Sciences Trust shares last traded at $37.6960, with a volume of 138,243 shares traded.

BlackRock Health Sciences Trust Trading Down 3.9%

The firm’s 50-day moving average price is $41.28 and its two-hundred day moving average price is $40.01.

BlackRock Health Sciences Trust Announces Dividend

The company also recently announced a monthly dividend, which will be paid on Tuesday, June 30th. Stockholders of record on Monday, June 15th will be issued a $0.2621 dividend. This represents a c) annualized dividend and a dividend yield of 8.3%. The ex-dividend date of this dividend is Monday, June 15th.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the company. Northwestern Mutual Wealth Management Co. raised its stake in BlackRock Health Sciences Trust by 22.2% during the 3rd quarter. Northwestern Mutual Wealth Management Co. now owns 1,417 shares of the company’s stock valued at $53,000 after acquiring an additional 257 shares during the last quarter. AlphaStar Capital Management LLC raised its position in BlackRock Health Sciences Trust by 2.2% during the 4th quarter. AlphaStar Capital Management LLC now owns 12,099 shares of the company’s stock worth $498,000 after buying an additional 258 shares during the last quarter. Oppenheimer & Co. Inc. boosted its holdings in shares of BlackRock Health Sciences Trust by 5.9% in the third quarter. Oppenheimer & Co. Inc. now owns 6,715 shares of the company’s stock valued at $250,000 after acquiring an additional 373 shares in the last quarter. SOA Wealth Advisors LLC. increased its stake in shares of BlackRock Health Sciences Trust by 20.3% during the third quarter. SOA Wealth Advisors LLC. now owns 2,780 shares of the company’s stock worth $103,000 after acquiring an additional 469 shares during the period. Finally, HBK Sorce Advisory LLC increased its stake in shares of BlackRock Health Sciences Trust by 3.8% during the fourth quarter. HBK Sorce Advisory LLC now owns 13,160 shares of the company’s stock worth $554,000 after acquiring an additional 476 shares during the period.

About BlackRock Health Sciences Trust

BlackRock Health Sciences Trust (NYSE: BME) is a closed-end management investment company that seeks long-term total return through a combination of dividend income and capital appreciation. Managed by BlackRock Fund Advisors, the trust invests primarily in the equity securities of domestic and international issuers engaged in the health sciences sector. The portfolio typically includes common stocks, corporate bonds and convertible securities of companies involved in biotechnology, pharmaceuticals, medical devices and healthcare services.